Trial intelligence / Profile preview

Tetracycline Pack in Marsupialization for Ameloblastoma

NCT06759610Completed

Sponsor
Minia University
Start
Feb 2024
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of tetracycline in unicystic ameloblastoma (UA) (2 arms), sponsored by Minia University. Primary endpoint: Radiographic assessment CBCT at 6 months. Started Feb 2024; status: completed.

02

Drugs

tetracycline
03

Conditions

unicystic ameloblastoma (UA)

Beyond the preview

Go deeper on NCT06759610.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06759610.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call